Global Superdisintegrants Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Superdisintegrants Market is presumed to reach the market size of nearly USD XX MN by 2030 from USD XX MN in 2022 with a CAGR of XX% under the study period 2023 - 2030.

Superdisintegrants are a type of excipient, which are inactive substances that are added to medications to aid in their manufacture, processing, and administration. Superdisintegrants are used to improve the disintegration of tablets and capsules in the gastrointestinal tract, which is necessary for the medication to be absorbed and effectively distributed throughout the body. Superdisintegrants work by rapidly swelling and breaking apart in the presence of moisture, which helps to create channels for water to enter the tablet or capsule, leading to its rapid disintegration. This improves the bioavailability and efficacy of the medication, as it allows for more rapid and efficient absorption. Commonly used superdisintegrants include cross-linked carboxymethyl cellulose, sodium starch glycolate, and croscarmellose sodium. These excipients are often combined with other excipients, such as binders and lubricants, to form a complete tablet or capsule formulation.

Market Dynamics

ODTs are rapidly disintegrating tablets that dissolve in the mouth without the need for water. They are increasingly popular for patients who have difficulty swallowing conventional tablets, such as the elderly and children. Superdisintegrants are a key ingredient in ODTs, and as demand for these products increases, so too does the demand for superdisintegrants. The global pharmaceutical industry is expected to showcase high growth due to factors such as aging population growth, the prevalence of chronic diseases, and the increasing availability of healthcare services in emerging markets. Superdisintegrants are a critical ingredient in many pharmaceutical formulations, and as the demand for medications increases, so does the demand for superdisintegrants. Patient compliance refers to a patient's willingness and ability to take medications as prescribed. Superdisintegrants can improve the ease of administration and absorption of medications, particularly for patients who have difficulty swallowing tablets or capsules. As healthcare providers and pharmaceutical companies focus more on patient compliance, the demand for superdisintegrants is expected to increase. The increasing availability of generic medications is driving the demand for superdisintegrants. Many generic manufacturers are looking to develop formulations that are equivalent to the brand-name product, and superdisintegrants can be used to improve the performance of the generic product. There has been ongoing research and development in the area of superdisintegrants, resulting in the development of newer and more effective products. This has led to increased adoption of these products in the pharmaceutical industry, particularly for use in ODTs and other rapidly disintegrating formulations.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of superdisintegrants. The growth and trends of superdisintegrants industry provide a holistic approach to this study.

Market Segmentation

This section of the superdisintegrants market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Natural Superdisintegrants
Synthetic Superdisintegrants
Other Superdisintegrants

By Formulation

Tablets
Capsules

By Therapeutic Area

Gastrointestinal Diseases
Neurological Diseases
Oncology
Infectious Diseases
Cardiovascular Diseases
Hematological Diseases
Inflmmatory Diseases

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Superdisintegrants market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the superdisintegrants market include BASF SE, Ashland Global Holding Inc., DowDuPont, Roquette Freres, DFE Pharma, JRS Pharma, Asahi Kasei Corporation, Merck KGaA, Corel Pharma Chem, Avantor Performance Materials. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112110821

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . SUPERDISINTEGRANTS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Formulation
- 3.7.3 Market Attractiveness Analysis By Therapeutic Area
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL SUPERDISINTEGRANTS MARKET ANALYSIS BY TYPE

5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Natural Superdisintegrants Historic and Forecast Sales by Regions
5.5 Synthetic Superdisintegrants Historic and Forecast Sales by Regions
5.6 Other Superdisintegrants Historic and Forecast Sales by Regions

6 . GLOBAL SUPERDISINTEGRANTS MARKET ANALYSIS BY FORMULATION

6.1 Overview by Formulation
6.2 Historical and Forecast Data
6.3 Analysis by Formulation
6.4 Tablets Historic and Forecast Sales by Regions
6.5 Capsules Historic and Forecast Sales by Regions

7 . GLOBAL SUPERDISINTEGRANTS MARKET ANALYSIS BY THERAPEUTIC AREA

7.1 Overview by Therapeutic Area
7.2 Historical and Forecast Data
7.3 Analysis by Therapeutic Area
7.4 Gastrointestinal Diseases Historic and Forecast Sales by Regions
7.5 Neurological Diseases Historic and Forecast Sales by Regions
7.6 Oncology Historic and Forecast Sales by Regions
7.7 Infectious Diseases Historic and Forecast Sales by Regions
7.8 Cardiovascular Diseases Historic and Forecast Sales by Regions
7.9 Hematological Diseases Historic and Forecast Sales by Regions
7.10. Inflmmatory Diseases Historic and Forecast Sales by Regions

8 . GLOBAL SUPERDISINTEGRANTS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE SUPERDISINTEGRANTS COMPANIES

9.1. Superdisintegrants Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF SUPERDISINTEGRANTS INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. BASF SE
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Ashland Global Holding Inc.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. DowDuPont
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Roquette Freres
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. DFE Pharma
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. JRS Pharma
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Asahi Kasei Corporation
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Merck KGaA
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Corel Pharma Chem
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Avantor Performance Materials
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies